Woolworths (ASX: WOW) outbids Wesfarmers (ASX: WES) for control of Australian Pharmaceutical (ASX:API)

The Wesfarmers (ASX: WES) and Woolworths (ASX: WOW) rivalry has been reignited today after Woolworths lobbed a $1.75 per share offer for Australian Pharmaceutical (ASX: API). 

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Wesfarmers Ltd (ASX: WES) and Woolworths Group Ltd (ASX: WOW) rivalry has been reignited today after Woolworths lobbed a $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API).

Previously, Wesfarmers had made a binding offer of $1.55 per share for the pharmacy chain, which had been recommended by the API board.

The deal looked largely complete until today’s shock announcement.

Wesfarmers and Woolworths were formerly fierce competitors in the supermarket sector before Wesfarmer’s spun off Coles Group Ltd

online pharmacy zovirax no prescription pharmacy

(ASX: COL) in 2018.

Battle for API heats up

Woolworths $1.75 per share cash offer via a scheme of arrangement values the Priceline Pharmacy chain owner at $872 million.

It’s a 20 cents per share or a 12.9% premium to Wesfarmers $1.55 per share proposal on November 8.

Woolworths’s bid is still subject to due diligence, which it believes will take four weeks.

On that timeline, a binding offer would be expected by mid-January 2022.

Woolworths deal is subject to regulatory approval, a unanimous recommendation by the API board and an Independent Expert concluding the bid is in shareholders best interests.

Wesfarmers still holds the ace

Woolworths audacious bid for API still has one critical hurdle to jump through.

Wesfarmers bought a 19.3% stake in API, therefore it holds a substantial share of voting power against any other proposal, including Woolworths.

Subsequently, Woolworths would need to convince the remaining 80.7% of API’s shareholders to vote in its favour.

A scheme of arrangement requires at least 75% of shareholder votes. Therefore, the supermarket giant would need at least 92% of API’s shareholders on its side should Wesfarmers vote against the deal – no easy task.

Woolworths has said it’s open to exploring alternative control structures, such as a takeover bid with acceptance of just 50.1%.

Nonetheless, Wesfarmers won’t roll over easily given it’s already fended off a competing offer from Sigma Healthcare Ltd (ASX: SIG).

The conglomerate has the right to match Woolworths bid, which would make for a fierce standoff.

API response

The API board has allowed Woolworths to undertake due diligence as it believes the offer is superior to Wesfarmers:

“…the API Board considers that the Woolworths Proposal is reasonably capable of being valued, implemented and completed in accordance with its terms, and, if completed substantially in accordance with its terms, be more favourable to API shareholders as a whole than the Wesfarmers Scheme”

My take

In what is generally a quiet month for corporate Australia, Woolworths, Wesfarmers and its bankers will be working feverishly to win control for API.

I’d expect Wesfarmers to match the bid, and then force Woolworths to other raise or walk away.

Either way, the battle for API looks to be heating up again.

To keep up to date on all the latest news regarding the API takeover, be sure to bookmark the Rask Media home page.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.